Since 2020, DIASYSTEMS has been actively developing in genomic research area — from microbiological analysis to diagnostics of orphan and hereditary diseases. The company also develops reagent kits and bioinformatics software platform that unify science and technology with clinical practice.
PRODUCTS
INFECTIONS
Human Genetics